HoGA Capital AG: Thousands of visitors marveled at Castello CUBE during Biennale – European premiere for unique golden artwork in Venice

(Venice, Italy): – The artwork is made of 24-carat, 999.9 fine gold, weighing 186 kilos. To create a work like this has been a pioneering achievement.
The excitement of the people in Venice made the silent object part of a lively happening. Children carefully touched its surface; groups of people took cheerful selfies; art experts discussed the expressiveness and effects of the object.
Art historian Dr. Dieter Buchhart: „The CUBE is a conceptual work that seems to have arrived from another world and is now standing on the cobbles of Venice, without a pedestal.”
Sven Wenzel: “The inimitable artwork by Niclas Castello pioneers a connection between the real artworld and the digital artworld (NFTs).”
This has been made possible by the art and NFT platform “Castello Forum”, which operates with the new crypto currency Castello Coin.
The aim of the platform is to promote talented artists’ projects around the world; to establish them, and to make them accessible to broader audiences.
The artwork is exhibited in public places so that it is accessible to everyone and people have the opportunity to rediscover art in the open space.
please find press assets under this link:
https://drive.google.com/drive/u/1/folders/1Cq6SFkbUGdSeHjzB91IxYJ6RkNfOws9M
- Picture is available at AP Images (http://www.apimages.com) -
Contacts
Lisa Schink
Tel:+491735430455press@castellocube.comImages

About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Biomay Obtains FDA Approval for Manufacturing of Cas9 Nuclease at Headquarters Site29.4.2025 14:00:00 CEST | Press release
The company announced its successful approval by the U.S. Food and Drug Administration (FDA) for the manufacturing, testing and release of recombinant Cas9 nuclease from its headquarters site. Cas9 is an essential component of CRISPR-based gene editing therapies, including CASGEVY® (exagamglogene autotemcel) developed and launched by Vertex Pharmaceuticals.
Bertelsmann Stiftung: Growth and innovation as cornerstones of a strong de-mocracy and a digitally sovereign Europe29.4.2025 12:00:00 CEST | Press release
Germany should be restored to a growth path and should give new impulse to innovation, along with its European partners. Because prosperity is a significant guarantor of a stable democracy. Digital sovereignty is the anchor of a strong Europe. Germany can once again be a country of pioneering innovation and a pacesetter for the continent. For this, comprehensive modernization of the state is indispensable. The Bertelsmann Stiftung presented its proposals at the annual press conference.
Acousia Therapeutics Reaches 50% Patient Enrollment Milestone in Phase 2 PROHEAR Study29.4.2025 09:00:00 CEST | Press release
Tübingen, Germany, April 29, 2025 Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study, evaluating ACOU085 (INN: bimokalner) for the prevention of cisplatin-induced hearing loss in patients with testicular cancer undergoing chemotherapy.
Australia’s next government must mend structural cracks appearing in its political, economic and social foundation, report finds28.4.2025 08:33:05 CEST | Press release
Australia boasts some of the world’s most sophisticated political institutions and one of its wealthiest economies. But this veneer of success masks deeper structural issues — and a “ticking time bomb” of overreliance on extractive industries must be addressed under Australia’s next government, a new report recommends.
EOPA Best Business Product of the Year 2025 - DYMO LetraTag 200B (Source:OPI)25.4.2025 08:00:04 CEST | Press release
DYMO® LETRATAG 200B WINS PRESTIGIOUS “BUSINESS PRODUCT OF THE YEAR” AWARD - REINFORCING RISE OF SMART ORGANIZATION
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom